IDH2 and chondrosarcoma: Nevertheless, the epigenetics compound screens identified several other classes of interesting drug targets for both IDH wildtype and IDH mutant chondrosarcoma, among which inhibitors against Aurora kinases, FLT3, HDAC, and JAK showed the most pronounced effect on chondrosarcoma cell growth.